Trials / Terminated
TerminatedNCT02579993
ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation
ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation Expanded in Vitro on Amniotic Membrane in Patients With Limbal Stem Cell Deficiency.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
In this study the prognostic value of ABCB5 in survival of the limbal stem cell transplantation expanded in vitro on amniotic membrane for corneal surface reconstruction in patients with limbal stem cell deficiency will be analyzed.
Detailed description
There are several diseases that cause the cornea to lose its clarity and directly affects the vision of the individual, therefore, the use of limbal stem cells has been having increasing acceptance in the field of medical therapy. An open clinical study is running with patients with limbal stem cell deficiency, performing a limbal stem cell transplantation expanded in vitro on amniotic membrane and the value of ABCB5 as a prognostic factor in the survival of transplant will be determined. The corneal surface status will be the primary endpoint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pannus and conjunctival dissection | A complete conjunctival peritomy is performed and the fibrovascular pannus and conjunctiva invading the cornea is dissected from the cornea and limbus. |
| PROCEDURE | Human cultivated limbal stem cell transplantation | The amniotic membrane graft cultured with the human limbal stem cell transplantation is placed in the limbic and corneal surface and fixed with fibrin glue. The amniotic membrane is placed with the stroma in contact with the graft and it is sutured. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2015-10-20
- Last updated
- 2018-03-06
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT02579993. Inclusion in this directory is not an endorsement.